{"nct_id":"NCT04725188","title":"Pembrolizumab/Vibostolimab Coformulation (MK-7684A) or Pembrolizumab/Vibostolimab Coformulation Plus Docetaxel Versus Docetaxel for Metastatic Non Small Cell Lung Cancer (NSCLC) With Progressive Disease After Platinum Doublet Chemotherapy and Immunotherapy (MK-7684A-002, KEYVIBE-002)","status":"COMPLETED","status_verified_date":"2025-07","start_date":"2021-04-20","start_date_type":"ACTUAL","primary_completion_date":"2023-01-26","primary_completion_date_type":"ACTUAL","completion_date":"2024-10-17","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MRK"]}